What attributes--mechanistically, metabolically, and physiologically--of GLP-1 RAs, in your mind, support their position as foundational agents across a broad spectrum of patients with T2D?

What attributes--mechanistically, metabolically, and physiologically--of GLP-1 RAs, in your mind, support their position as foundational agents across a broad spectrum of patients with T2D?

What attributes—mechanistically, metabolically, and physiologically—of GLP-1 RAs, in your mind, support their position as foundational agents across a broad spectrum of patients with T2D?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Ralph DeFronzo, MD

Ralph DeFronzo, MD

Professor of Medicine Chief of the Diabetes Division The University of Texas Health Science Center at San Antonio San Antonio, Texas